Establishes Second Clinical Trial Site for US Phase I Clinical Study of Trappsol(r) Cyclo(TM) for Treatment of Niemann Pick Disease Type C

Press/Media: Press / Media

PeriodOct 5 2018

Media coverage

4

Media coverage

  • TitleEstablishes Second Clinical Trial Site for US Phase I Clinical Study of Trappsol(r) Cyclo(TM) for Treatment of Niemann Pick Disease Type C
    Media name/outletMarket News Publishing
    CountryUnited States
    Date10/5/18
    PersonsDarius Adams
  • TitleEstablishes Second Clinical Trial Site for US Phase I Clinical Study of Trappsol(r) Cyclo(TM) for Treatment of Niemann Pick Disease Type C
    Media name/outletMarket News Publishing
    CountryUnited States
    Date10/5/18
    PersonsDarius Adams
  • TitleCTD Holdings Establishes Second Clinical Trial Site for US Phase I Clinical Study of Trappsol® Cyclo„¢ for Treatment of Niemann-Pick Disease Type C
    Media name/outletPrimeNewswire (Top News)
    CountryUnited States
    Date10/5/18
    PersonsDarius Adams
  • TitleCTD Holdings Establishes Second Clinical Trial Site for US Phase I Clinical Study of Trappsol® Cyclo„¢ for Treatment of Niemann-Pick Disease Type C
    Media name/outletPrimeNewswire (XML)
    CountryUnited States
    Date10/5/18
    PersonsDarius Adams